David Hochman

David Hochman

Chief Executive Officer at ORCHESTRA BIOMED HOLDINGS, INC.

Net worth: 6 M $ as of 30/05/2026

50 year
Health Technology
Finance
Health Services

Profile

David P.
Hochman
is the founder of OPKO Biologics Ltd. (2001), Prescient Medical, Inc. (2004), Caliber Therapeutics LLC (2009), FreeHold Surgical LLC (2011), BackBeat Medical LLC (2011), Corbus Pharmaceuticals Holdings, Inc. (2013), Orchestra BioMed, Inc. (2018), and Orchestra Biomed Holdings, Inc. (2020).
Titles held at these companies included Director at OPKO Biologics Ltd. (2005–2007), Director at Caliber Therapeutics LLC (2009–2018), Director at FreeHold Surgical LLC (2011–2018), Director at BackBeat Medical LLC (2018), Director at Corbus Pharmaceuticals Holdings, Inc. (2013–2020), Chairman & Chief Executive Officer at Orchestra BioMed, Inc. (2018–present), and Chairman & Chief Executive Officer at Orchestra Biomed Holdings, Inc. (2020–present).
Current jobs include Chairman at Motus G.I.
Medical Technologies Ltd. (2011–present), Director at Corbus Pharmaceuticals, Inc., Director at Aids Action Foundation, and President & Director at Mollie Parnis Livingston Foundation, Inc.Former jobs include Chief Executive Officer at Spencer Trask Edison Partners LLC (1997–2006), Vice Chairman at Naked Brand Group, Inc. (2014–2017), Chairman at Vital Access Corp.
(2008–2017), Director at Orchestra Therapeutics, Inc., Managing Director at Augment Securities, Inc. (2005), Director at Journey Health, Inc. (Virginia) (2013–2018), Director at Citizens Committee for New York City (1999–2019), Director at Adgero Biopharmaceuticals Holdings, Inc. (2015–2020), Independent Director at Motus GI Holdings, Inc. (2023), Advisor at Idera Pharmaceuticals, Inc., Advisor at Health Dialog Services Corp., Managing Partner at Orchestra Medical Ventures LLC, and President at Accelerated Technologies, Inc. (Texas) (2009–2019).
Education includes undergraduate degree from the University of Michigan, conferred in 1997.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/06/2026 1,506,085 ( 2.79% ) 6 M $ 30/05/2026

David Hochman active positions

CompaniesPositionStart
ORCHESTRA BIOMED HOLDINGS, INC. Chief Executive Officer 24/05/2020
Director/Board Member -
Chief Executive Officer 30/04/2018
Chairman 31/08/2011
Mollie Parnis Livingston Foundation, Inc.
President -
Director/Board Member -

Former positions of David Hochman

CompaniesPositionEnd
MOTUS GI HOLDINGS, INC. Chairman 12/04/2023
CORBUS PHARMACEUTICALS HOLDINGS, INC. Founder 10/09/2020
Director/Board Member 31/12/2019
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of David Hochman's experience

Training of David Hochman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies26

Finance

Health Technology

Health Services

Finance

Distribution Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Producer Manufacturing

Spencer Trask Edison Partners LLC

Health Technology

Electronic Technology

Commercial Services

Mollie Parnis Livingston Foundation, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!